Audentes Therapeutics, Inc.

• Accepted (ET)
• Feb 14SC 13G/A—
  Audentes Therapeutics, Inc.0001104659-20-021813 · 67.4 KB
  SEC(opens sec.gov)
• Feb 14SC 13G/A—
  Audentes Therapeutics, Inc.0001172661-20-000840 · 109.2 KB
  SEC(opens sec.gov)
• Feb 14SC 13G/A—
  Audentes Therapeutics, Inc.0001104659-20-021676 · 153.9 KB
  SEC(opens sec.gov)
• Feb 11SC 13G—
  Audentes Therapeutics, Inc.0001104659-20-016339 · 13.7 KB
  SEC(opens sec.gov)
• Feb 5SC 13G/A—
  Audentes Therapeutics, Inc.0000834237-20-004619 · 13.4 KB
  SEC(opens sec.gov)
• Jan 158-K—
  Current report0001193125-20-007673 · 311.6 KB
  SEC(opens sec.gov)
• Jan 7SC 13G/A—
  Audentes Therapeutics, Inc.0000902219-20-000003 · 33.4 KB
  SEC(opens sec.gov)
• Dec 168-K—
  Current report0001193125-19-314351 · 169.3 KB
  SEC(opens sec.gov)
• Dec 28-K—
  Current report0001193125-19-304554 · 1.0 MB
  SEC(opens sec.gov)
• Nov 12SC 13G/A—
  Audentes Therapeutics, Inc.0000315066-19-001760 · 8.4 KB
  SEC(opens sec.gov)

• 5AM VENTURES III, L.P.former 10% owner
• Conner Edward R.SVP, Chief Medical Officer
• DEERFIELD MANAGEMENT COMPANY, L.P.10% Owner, Possible Member of 10% Group
• Deerfield Mgmt L.P.10% Owner, Possible Member of 10% Group
• Deerfield Private Design Fund III, L.P.10% Owner, Possible Member of 10% Group
• DIEKMAN JOHN DFomer 10% owner
• Flynn James E10% Owner, Possible Member of 10% Group
• Goldberg Mark AlanDirector
• GRAY JOHN T.SVP, Chief Scientific Officer
• Holles Natalie C.President and COO

No tickers on record.

• business

  600 CALIFORNIA ST., 17TH FLOOR

  SAN FRANCISCO, CA, 94108

• mailing

  600 CALIFORNIA ST., 17TH FLOOR

  SAN FRANCISCO, CA, 94108